Cas 943772-55-2,[4-(2-nitro-4-p-tolylcarbamoyl-phenoxy)-phenyl]-carbamic acid tert-butyl ester

943772-55-2

Post Buying Request

Basic information

Product Name: [4-(2-nitro-4-p-tolylcarbamoyl-phenoxy)-phenyl]-carbamic acid tert-butyl ester
Synonyms: [4-(2-nitro-4-p-tolylcarbamoyl-phenoxy)-phenyl]-carbamic acid tert-butyl ester
CAS NO:943772-55-2
Molecular Formula:
Molecular Weight: 463.49
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [4-(2-nitro-4-p-tolylcarbamoyl-phenoxy)-phenyl]-carbamic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: [4-(2-nitro-4-p-tolylcarbamoyl-phenoxy)-phenyl]-carbamic acid tert-butyl ester(943772-55-2)
EPA Substance Registry System: [4-(2-nitro-4-p-tolylcarbamoyl-phenoxy)-phenyl]-carbamic acid tert-butyl ester(943772-55-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 943772-55-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

943772-55-2 Suppliers

Recommended suppliers

943772-55-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 943772-55-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,7,7 and 2 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 943772-55:
(8*9)+(7*4)+(6*3)+(5*7)+(4*7)+(3*2)+(2*5)+(1*5)=202
202 % 10 = 2
So 943772-55-2 is a valid CAS Registry Number.

943772-55-2Upstream product

943772-55-2Downstream Products

943772-55-2Relevant academic research and scientific papers

ANTI-VIRAL COMPOUNDS

-

Page/Page column 120, (2010/11/27)

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 943772-55-2